05:30

Novel and Emerging Treatment Strategies for Narcolepsy

09:00

Navigating How the Updated ASCCP Guidelines Can Work for You

12:00

Uncovering New Biomarkers for RCC: A Review of Emerging Techniques

09:00

Navigating How the Updated ASCCP Guidelines Can Work for You

05:00

The Potential Impact of RCC Molecular Subtypes on Treatment Outcomes

05:00

Beyond Guesswork: Validated Methods for MCI Assessment in Alzheimer's Diagnosis

05:30

Comparative Efficacy: SubQ vs. Intravenous DMTs in Alzheimer's Disease

05:00

The Subtle Onset: Understanding Early MCI AD Symptoms

05:00

Therapeutic Insights: Navigating the Use and Challenges of Disease-Modifying Therapies

05:00

Inequity and Illness: Understanding MCI Disease Course and Severity for Racial Minorities

05:30

Precision Imaging: MRI's Critical Role in Early MCI AD Diagnosis

05:00

Markers of Memory: Pathological Biomarkers of Clinical MCI Due to AD

05:00

Dementia on a Spectrum: Preclinical Stages of MCI in AD

04:30

Future Frontiers: The Future Landscape of Alzheimer's Therapeutics

05:30

Breaking Ground: The Latest Data on AD Disease-Modifying Therapies

25:30

Chairperson Perspective: Practice-Changing Strategies in Community Care Settings for Patients wit...

11:00

Delivering Guideline-Based Hepatocellular Carcinoma Care with an Interactive Tool

06:00

Exploring Autophagy through Sigma-1 Receptor Activation: Innovative Therapeutics for Alzheimer's ...

05:30

Managing Treatment-Related Toxicities With JAK Inhibitor Therapy in Myelofibrosis

05:00

Treatment Options for Ruxolitinib Intolerance or Resistance in Myelofibrosis

32:30

Chairperson Perspective: Precision Payloads: Exploring ADC-Directed Therapies in HER2-Mutant and ...

04:30

How and When to Manage Ruxolitinib Failure

05:00

Improving Transfusion Independence With JAK Inhibitor Therapy

05:00

How to Use Prognostic Risk Scoring and Symptom Burden Assessment to Tailor Myelofibrosis Treatment

04:30

Managing Myelofibrosis-Associated Thrombocytopenia

04:00

Pacritinib for Myelofibrosis Across the Cytopenic Spectrum

04:00

Managing Myelofibrosis-Associated Anemia

04:00

Case Discussion: What JAK Inhibitor Should I Use in a Transfusion-Dependent Patient With MF With ...

51:00

Myeloma Matters: Prevention and Management of Bispecific Antibody–Associated Adverse Events in Mu...

27:30

Advancements in GU Cancers: Key Data from AUA 2024

01:16:00

Case by Case: Optimizing Dual Immune Checkpoint Inhibitor Combination Therapies in Advanced Drive...

05:30

Enhancing Outcomes in Unresectable HCC Through Integrated Multidisciplinary Care Models

05:30

Emerging First-Line ICI Combination Regimens in Patients With Unresectable HCC

05:30

Managing Adverse Events Associated With ICI Combinations in Patients With Unresectable HCC

04:30

Current Unmet Needs in the Field of Unresectable HCC

05:30

Pivotal Data Supporting First-Line Atezolizumab/Bevacizumab in Unresectable HCC

05:00

Empowering Treatment Choice: The Essential Role of Shared Decision-Making in Unresectable HCC

05:00

Selecting the Optimal ICI Partner for First-Line Treatment of Unresectable HCC: CTLA-4 vs VEGF In...

03:30

Use of ICI Combination Regimens in Patients With Intermediate-Stage HCC

05:30

Pivotal Data Supporting First-Line Durvalumab/Tremelimumab in Unresectable HCC

04:30

Case Consult: Treatment Options for an Unresectable HCC Patient Who Has Esophageal Varices

12:00

Emerging Frontiers: CAR T-Cell Therapy for Solid Tumors in Thyroid Cancer

01:00:00

Optimizing Biomarker Testing to Guide Treatment Selection for Metastatic Colorectal Cancer

01:00:00

Optimizing Biomarker Testing to Guide Treatment Selection for Metastatic Colorectal Cancer

14:00

MCED Testing: Confirming a Positive Result with Diagnostic Follow-Up

43:00

Spinal Muscular Atrophy: Optimizing the Management of Adults in the Era of Disease-Modifying Ther...

09:30

Dual Challenges: Managing Hepatocellular Carcinoma with Hepatitis B Co-Infection

05:00

Current Updates in Brain Imaging and Neurodegenerative Diseases

09:00

Importance of a Timely Postpartum Depression Diagnosis: Patient Perspectives

09:00

Importance of a Timely Postpartum Depression Diagnosis: Patient Perspectives

09:30

Uncovering Barriers to HCC Surveillance in Patients with Cirrhosis

54:30

Multiple Myeloma Care: Translating Evolving Practices to Oncology Nurses in Community Settings

54:30

Multiple Myeloma Care: Translating Evolving Practices to Oncology Nurses in Community Settings

06:30

Salivary Toxicity from PSMA-Targeted Radiopharmaceuticals in mCRPC

06:30

Salivary Toxicity from PSMA-Targeted Radiopharmaceuticals in mCRPC

12:30

A Look at the Utility of PSMA PET Scans in Prostate Cancer

12:30

A Look at the Utility of PSMA PET Scans in Prostate Cancer

02:30

AI in Nuclear Medicine: Improvements in the Field

04:00

Diving into New Directions of Radiopharmaceuticals

18:30

Exploring the Spectrum of Efficacy in Emerging Schizophrenia Therapies: From Positive to Negative...